Consumer Representative Is Lone Voice Against Approving TOBI Podhaler
Executive Summary
Rodney Mullins, national director of Public Health Consultants and Advocates, cast the lone vote on FDA’s Anti-Infective Drugs Advisory Committee against approving Novartis’ TOBI Podhaler for the management of cystic fibrosis patients infected with Pseudomonas aeruginosa.